Vimarsana
Biggest News Aggregation in the World

Page 14 - Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

Soligenix Announces Submission of New Drug Application to the FDA for HyBryte™ in the Treatment of Cutaneous T-cell Lymphoma - Vimarsana News

Soligenix Announces Submission of New Drug Application to the FDA for HyBryte™ in the Treatment of Cutaneous T-cell Lymphoma

Published: December 15, 2022

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Source: prnewswire.com
Related Topics:
United StatesChristopherj SchaberUs CongressNational Institute Of AllergyWhile The CompanySoligenix IncDefense Threat Reduction AgencyUs DevelopmentPrnewswire Soligenix IncBiomedical Advanced ResearchDrug AdministrationDevelopment AuthorityExchange CommissionEuropean Medicines AgencyOur Public Health SolutionsChief Executive OfficerAbout Cutaneoust Cell LymphomaPublic Health SolutionsNational InstituteInfectious DiseasesProject BioshieldPriority Review Voucher
Local agency celebrates 1 million tissue grafts in 2022 - Vimarsana News

Local agency celebrates 1 million tissue grafts in 2022

Published: December 7, 2022

Community Blood Center/Community Tissue Services is celebrating a historic milestone — the agency distributed a record one million tissue grafts in 2022 alone.

Source: wksu.org
Related Topics:
United StatesBiomedical Advanced ResearchUs Department Of HealthHuman ServicesAdministration For Strategic PreparednessDevelopment AuthorityBusiness Development Paul LehnerCommunity Blood Center Tissue ServicesCommunity BloodCommunity Tissue ServicesBusiness Development PaulProject BioshieldStrategic Preparedness
Local agency celebrates 1 million tissue grafts in 2022 - Vimarsana News

Local agency celebrates 1 million tissue grafts in 2022

Published: December 6, 2022

Community Blood Center/Community Tissue Services is celebrating a historic milestone — the agency distributed a record one million tissue grafts in 2022 alone.

Source: wvxu.org
Related Topics:
United StatesBiomedical Advanced ResearchUs Department Of HealthHuman ServicesAdministration For Strategic PreparednessDevelopment AuthorityBusiness Development Paul LehnerCommunity Blood Center Tissue ServicesCommunity BloodCommunity Tissue ServicesBusiness Development PaulProject BioshieldStrategic Preparedness
Soligenix to Receive $1.2 M in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program - Vimarsana News

Soligenix to Receive $1.2 M in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program

Published: November 15, 2022

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Source: prnewswire.com
Related Topics:
New JerseyUnited StatesState Of New JerseyChristopherj SchaberUs CongressJersey Technology Business Tax CertificateNational Institute Of AllergyJersey Division Of TaxationJersey Economic Development AuthoritySoligenix IncJersey Commission On ScienceDefense Threat Reduction AgencyDrug Administration For HybryteUs DevelopmentPrnewswire Soligenix IncBiomedical Advanced ResearchDevelopment AuthorityDevelopment Rd TaxExchange CommissionOur Public Health SolutionsNew Jersey Economic Development AuthorityNet Operating LossChief Executive OfficerDrug AdministrationTax Credits
Soligenix Announces Recent Accomplishments And Third Quarter 2022 Financial Results - Vimarsana News

Soligenix Announces Recent Accomplishments And Third Quarter 2022 Financial Results

Published: November 10, 2022

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Source: prnewswire.com
Related Topics:
Christopherj SchaberUs CongressNational Institute Of AllergyEmergent Biosolutions IncProducts DevelopmentSoligenix IncDefense Threat Reduction AgencyUs DevelopmentBiomedical Advanced ResearchDrug AdministrationDevelopment AuthorityExchange CommissionDivision Of ChemicalOur Public Health SolutionsChief Executive OfficerMedical Advisory BoardNational InstituteInfectious DiseasesMedical CountermeasuresOrphan Products DevelopmentQuarter Ended SeptemberEmergent BiosolutionsShareholder MeetingPublic Health SolutionsProject Bioshield